Request for Applications: Patient-Partnered Single-Cell Analysis of Rare Pediatric Disease RFA
CZI Science Logo ([link removed] )
Image of scientists working together ([link removed] )
Request for Applications: Patient-Partnered Single-Cell Analysis of Rare Pediatric Disease RFA
Applications due May 24, 2022 by 5 p.m. Pacific Time
Apply Now
([link removed] )
The application deadline for the Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease ([link removed] ) is approaching.
The Chan Zuckerberg Initiative (CZI) invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. This RFA aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases that will clarify cellular mechanisms of disease, understand disease heterogeneity, and improve biomarker identification or diagnostics.
The awards cover $2 million in total costs for four years for each project, distributed among research institutions and a patient organization. Applications are due May 24, 2022 at 5 p.m. Pacific Time. Full details here ([link removed] ) .
Questions? Email
[email protected] (mailto:
[email protected]) .
CZI Science Twitter illustration ([link removed] )
Follow CZI Science on Twitter ([link removed] ) and Medium ([link removed] )
CZI Science Medium Illustration ([link removed] )
Stay Connected with the Chan Zuckerberg Initiative
Facebook ([link removed] )
Twitter ([link removed] )
Instagram ([link removed] )
LinkedIn ([link removed] )
YouTube ([link removed] )
CZI Foundation | P.O. Box 8040, Redwood City, CA 94063
Manage Preferences ([link removed] ) | Unsubscribe from All ([link removed] )
View in browser ([link removed] )
